Dietrich A. Stephan

Insider Reports History

Location
Pittsburgh, PA
Signature
/s/ Todd P. Branning
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dietrich A. Stephan:

Company Role Class Num Shares Value Price $ Report Date Ownership
NeuBase Therapeutics, Inc. Founder and CEO, Director, 10%+ Owner Common Stock 93,234 $179,009 $1.92 02 Aug 2023 Direct
NeuBase Therapeutics, Inc. Founder and CEO, Director, 10%+ Owner Common Stock 63,690 $122,285 $1.92 02 Aug 2023 Indirect
NeuBase Therapeutics, Inc. Founder and CEO, Director, 10%+ Owner Stock option (right to buy) 0 02 Aug 2023 Direct

Insider Reports Filed by Dietrich A. Stephan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBSE NeuBase Therapeutics, Inc. 02 Aug 2023 2 $2,051 4 Founder and CEO, Director, 10%+ Owner 04 Aug 2023, 16:39
NBSE NeuBase Therapeutics, Inc. 16 Mar 2023 1 $0 4 CEO and Director, Director, 10%+ Owner 17 Mar 2023, 16:11
NBSE NeuBase Therapeutics, Inc. 13 Feb 2023 2 $0 4 President and CEO, Director, 10%+ Owner 15 Feb 2023, 18:30
NBSE NeuBase Therapeutics, Inc. 28 Sep 2022 2 $0 4 CEO, Director, 10%+ Owner 30 Sep 2022, 19:45
NBSE NeuBase Therapeutics, Inc. 24 Jan 2022 1 $0 4 President and CEO, Director, 10%+ Owner 25 Jan 2022, 12:50
NBSE NeuBase Therapeutics, Inc. 31 Dec 2021 2 $0 4 President and CEO, Director, 10%+ Owner 05 Jan 2022, 20:45